Safety and efficacy of autologous human schwann cell (ahsc) augmentation in severe peripheral nerve injury (PNI)
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2211048
- Recipient
-
University Of Miami UEI F8THLJQSAF93 Part of University Of Miami
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,500,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Miami, FL 33136, USA
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Miami to support research on the "Safety and Efficacy of Autologous Human Schwann Cell (AHSC) Augmentation in Severe Peripheral Nerve Injury (PNI)." The grant period runs from September 30, 2022 to September 29, 2026.
The research aims to investigate using a patient's own Schwann cells, which support nerve growth, to treat severe injuries to peripheral nerves. This work aligns with the goals of the Military Medical Research and Development program's CFDA #12.420, which supports biomedical research to develop innovative medical solutions for service members and the public. The University of Miami will leverage its expertise in regenerative medicine to advance treatment options for peripheral nerve damage.
Quick answers
Who received award W81XWH2211048?
W81XWH2211048 was awarded to University Of Miami by Medical Command (Department of the Army) on September 30, 2022.
How much is award W81XWH2211048 worth?
$1,500,000 has been obligated on W81XWH2211048.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award